J. Tod Fetherling, Huron managing director, surveys the panel he’ll present at HIMSS23 regarding models the panelists developed that can help predict lung cancer and how to translate analytics into patient communication.
J. Tod Fetherling will offer more detail during his HIMSS23 session "Using AI to Predict Lung Cancer." It's scheduled for Thursday, April 20, at 1-2 p.m. CT at the South Building in room S103.
